Cargando…
SAT-147 Endogenous Expression of TCF21 by CRISPR/dCas9 System Results in Different Biological Responses in Adrenocortical Carcinoma and Hepatocarcinoma
Transcription factor 21 (TCF21/POD-1/Epicardin) inhibits the expression of SF-1 (NR5A1) by binding to the promoter E-box site in adrenocortical carcinoma (ACC). In contrast, TCF21 promotes increased expression of LRH-1 in hepatocarcinoma cell line, HepG2 cells, by binding to the Small Heterodimer Pa...
Autores principales: | Kremer, Jean Lucas, Passaia, Barbara dos santos, Lotfi, Claudimara Ferini Pacicco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207456/ http://dx.doi.org/10.1210/jendso/bvaa046.1064 |
Ejemplares similares
-
Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells
por: Kremer, Jean Lucas, et al.
Publicado: (2021) -
POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells
por: França, Monica Malheiros, et al.
Publicado: (2015) -
New evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells
por: França, Monica Malheiros, et al.
Publicado: (2017) -
TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors
por: Passaia, Barbara dos Santos, et al.
Publicado: (2018) -
The human adrenal cortex: growth control and disorders
por: Lotfi, Claudimara Ferini Pacicco, et al.
Publicado: (2018)